Partnerships happen when two companies with ND agreements come to terms because of the outstanding results. One has to remember the pre clinical drug recently received a major league partnership agreement. Why, the BP company has the dollars, they know the current research accomplishments of the company and could not let the opportunity to accelerate something they believe will complete clinical trials to FDA approval escape. It's all about risk vs. outcome and how fast to market. IPIX has, is completing trials and has information they share with companies that are under NDAs. If they have multiple companies under NDAs for the same candidate, the competition is there, who pulls the trigger first. Lots of ways this can happen and partnerships is on the top of Leo's wish list. We'll see. Leo could be turning down offers from them at the same time, going further with clinical trials thanks to his cash position, until he gets the offer he believes is the best for the company, short and long term and both parties involved and insures the candidate completes the FDA approval process and it goes to market.
Feel free to think what you want, that it's ok to just ramble on. Retail ahead of itself, LMAO, ROF. Leo said, 2017 is the year of the partnership. Not surprised, it always takes longer but he has again mentioned late stage partnership negotiations so one might take him at his word. Write to me next in January of 2019............ until then...
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links